PGAM1 and pulmonary fibrosis: As FOXM1 accumulates in aged tissues, chemical or genetic abrogation of PGAM1-Chk1 binding impedes the protective role of FOXM1 in SnCs, inducing the death of senescent cells and alleviating dysfunction, including lung fibrosis, in vivo, indicating its potential efficacy as senotherapy.